Academic General Pediatrics Fellowship
Fellowship Steering Committee
General Pediatrics Residency
Metabolic Bone Clinic
Fellowship Program Director
John D. Mahan, MD, is the Program Director for the Nationwide Children’s Hospital/ The Ohio State University(OSU) Pediatric Residency Program and a Professor of Pediatrics at The Ohio State University (OSU) College of Medicine. Additionally, he is Program Director of the Pediatric Nephrology fellowship program. Dr. Mahan received his medical degree from Hahnemann Medical College. His clinical interests include pediatric dialysis and renal transplantation, growth failure in children with chronic kidney disease, treatments of hemolytic uremic syndrome and glomerulonephritis and metabolic bone disorders in children. His research interests are primarily associated with emerging therapies in pediatric dialysis and renal transplantation, growth hormone therapy in children with chronic kidney disease, bisphosphonate therapy in children with metabolic bone disease and osteoporosis and advances in learning technology in medical education. Dr. Mahan is principal investigator in a study of the effectiveness of recombinant growth hormone in treatment of growth failure in children with osteogenesis imperfecta on bisphosphonate therapy. He is a co-investigator in two National Institutes of Health-sponsored clinical trials: treatment of children with FSGS and the prospective study of chronic kidney disease in children. He is a principal investigator or co-investigator in eight active studies devoted to treatments in children with renal transplantation, metabolic bone disease and hypertension. Dr. Mahan also serves as chairman of the Post-Doctoral Education Committee for the Department of Pediatrics, the Nationwide Children’s Hospital Library Committee and the Medical Advisory Board of the National Kidney Foundation of Ohio. He is an elected board member of the Association of Pediatric Program Directors.